Channel Avatar

The 10X Capital Podcast with David Weisburd @UCncFI0XEvTu7k4er6BgVN9g@youtube.com

4.1K subscribers - no pronouns :c

David Weisburd interviews LPs and GPs to examine the Venture


36:15
Carrie Thome & Grady Buchanan of NVNG on How to Raise Capital from Corporate LPs | E38
01:27
Elon's Best Friend: "He is P.T. Barnum."
01:01:29
Errik Anderson on Co-Founding 20 Biotech Startups Cumulatively Worth $10B+ | E37
01:09
Elon’s Best Friend: The Secret to Running 7 Companies at the Same Time
23:43
Masterclass on Portfolio Construction with Anubhav Srivastava, CEO of Tactyc | E36
42:25
Ben Gallacher, Cannonball on “Value per Dollar Invested” and How it Predicts Fund Performance | E35
01:34
Jake Paul and His Employees Got Matching Tattoos
03:46
David Friedberg explains his new genetics startup Ohalo
01:28
Jake Paul Reveals That His “Problem Child” Persona a Marketing Gimmick
01:00:22
Aakar Vachhani of Fairview on What The Top 1% of GP’s Share in Common | E34
34:56
Charmel Maynard, CIO of University of Miami on Building a Venture Book | E33
56:30
Ashby Monk, Stanford Professor on How to Become a Billionaire in Private Equity | E32
48:29
David Friedberg on How To Build a Billion Dollar Startup | E31
48:03
Alan Feld, Co-Founder of Vintage Investment Partners on How to Handle Succession in VC | E30
55:23
Lo Toney, Plexo Capital on How He Raised Capital from Google, the Ford Foundation, Mass Mutual | E29
21:55
What Makes Elon Musk So Effective? Elon’s Best Friend Explains
45:14
Roland Reynolds, Industry Ventures on Investing $7 Billion into Startups & Venture Funds | E28
34:49
Fernando Pontaza of Invariantes on Why 25% IRR is the Gold Standard in Venture | E27
50:28
Winter Mead of Coolwater on Building the YC for GPs
34:14
Jeff Galvin, CEO of Addimmune on Finding a Cure for HIV
01:02:48
Joshua Berkowitz of Berkocorp on Why LP’s Should Care about IRR% not TVPI | E24
26:31
How Israel’s Largest Hospital Delivers Care to Palestinians through “Peace Through Health” | E23
58:44
Alex Edelson of Slipstream on The 4 Sources of Alpha for Emerging Managers | E22
33:57
Jake Paul and Joey Levy of Betr on How to Build a $100 Billion Company | E21
54:14
James Heath, dara5 on How Family Offices Access Top Venture Funds | E20
38:47
Raja Doddala, Head of VC at Churchill ($47 Billion AUM) on How LP’s Should Diligence GP’s | E19
52:19
Avlok Kohli, CEO of AngelList on How He Turned AngelList into a $4 Billion Dollar Company | E18
42:13
Tracy Fong, Albourne Partners $700B+ AUA, on How Endowments Access Emerging Managers | E17
55:23
Beezer Clarkson on her new $1.4B Emerging Manager Fund with CalSTRS | E16
48:25
Scott Painter on His Relationship with Elon Musk and the Future of Mobility | Ep 15
40:21
Jason Calacanis on How He Returned 4,000X ($25K into $100MM) on a Single Investment | Episode 14
00:51
The Limited Partner Podcast Statement on the Hamas Terrorist Attack on 10/7
40:45
E13: Shai Goldman on What Differentiates Venture Funds that Generate 3X+ DPI?
49:44
E12: Jamie Rhode on Why 95% of LPs Can Only Achieve a 10% IRR when the Mean Return is 50% IRR
40:11
E11: Neil Datta, The Forbes Family Trust’s Approach to VC | Is there Alpha in Due Diligence?
50:53
E10: Michael Kim | Founder of Cendana Capital on How Small VC Funds Can Return 200X+
46:09
E9: David Clark | Investment Director at VenCap on What Every LP Gets Wrong About Power Laws
42:10
E8: Apurva Mehta of Summit Peak on Why Fee Sensitivity Leads to Adverse Selection in Venture
35:49
E7: Samir Kaji | Founder and CEO of Allocate on How the Top 5% of LP’s Invest in VC
29:25
E6: Steve Chasan | Head of Investments - Rothschild Foundation on how GPs Can Navigate the VC Reset
29:08
E5: Jonathan Hsu | Co-Founder of $1.6B AUM Tribe Capital on What Data Shows is Product Market Fit
52:42
E4: Dr. Abe Othman of AngelList | Data, Research, and Quantitative Investing in Venture Capital
34:11
E3: Ramzi Samara of MASIC | The Rise of Saudi Arabia and the MENA Region in Venture Capital
35:53
E2: Jordan Stein | How Cresset Partners Raised $40B, Invested in Andreessen Horowitz + Founders Fund
50:17
E1: Chris Douvos' Guide to Investing in Venture Capital in 2023